Roohi Ismail-Khan, MD, Oncology, Tampa, FL, H. Lee Moffitt Cancer Center and Research Institute

RoohiIsmail-KhanMDMSC

Oncology Tampa, FL

Breast Cancer, Hematologic Oncology

Associate Member, H. Lee Moffitt Cancer Center

Dr. Ismail-Khan is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ismail-Khan's full profile

Already have an account?

Education & Training

  • University of South FloridaM.S.M.S., Clinical and Translational Research, Cum Laude, 2006 - 2010
  • University of South Florida Morsani College of Medicine
    University of South Florida Morsani College of MedicineFellowship, Hematology/Oncology, 2005 - 2007
  • University of South Florida Morsani College of Medicine
    University of South Florida Morsani College of MedicineResidency, Internal Medicine, 2001 - 2004
  • St. George's University School of Medicine
    St. George's University School of MedicineClass of 2000
  • Wesleyan CollegeBSc, Biology/Psychology/English, Summa Vum Laude, 1991 - 1995

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2005 - 2021

Awards, Honors, & Recognition

  • Patient's Choice Award 2014, 2015 Vitals, 2015-2016
  • Most Compassionate Doctor Vitals, 2014-2015
  • Top Oncologists in Tampa, FL Award International Association of Oncologists, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Beta-catenin Expression Patterns in Matched Pre and Post Neoadjuvant Chemotherapy Resistant Breast Cancer  
    Rosa M, Han HS, Ismail-Khan R, Allam-Nandyala P, Bui M, Annals of Clinical and Laboratory Science, 1/1/2015
  • A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors  
    Soliman HH, Jackson E, Neuger T, Dees C, Harvey D, Han H, Ismail-Khan R, Minton SE, Vahanian N, Link C, Sullivan D, Antonia S, Oncotarget, 1/21/2014
  • Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estro...  
    Yardley D, Ismail-Khan R, Trepel J, et al, Journal Of Clinical Oncology, 1/6/2013
  • Join now to see all

Abstracts/Posters

  • A Phase II, open label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)
    Bardia A, Kummel S, Garcia-Estevez L, Huang CS, Cortes Castan J, Ruiz Borrego M, Telli ML, Lluch Hernandez A, Lopez R, Beck JT, Ismail-Khan R, Chen SC, Hurvitz S, Maye..., ASCO, Chicago, IL, 1/1/2015
  • The BCL2 antagonist of cell death (BAD) signaling pathway and phospho-BAD protein levels are associated with triple negative breast cancer clinical development and cli...
    Marchion DC, Xiong Y, Ismail-Khan R, Abbasi F, Bou Zgheib N, Ramirez IJ, Bush SH, Hakam A, Judson PL, Lancaster JM, SGO 45th Annual Meeting, Tampa, FL, 1/21/2014
  • AKT survival signaling and phospho-AKT expression are associated with triple negative breast cancer development and clinical outcome
    Marchion DC, Ismail-Khan R, Abbasi F, Boac B, Xiong Y, McClung C, Khulpateea BR, Bush SH, Hakam A, Lancaster JM, SGO 45th Annual Meeting, Tampa, FL, 1/21/2014
  • Join now to see all

Lectures

  • Cardiac Complications from Chemotherapy and The New Cardio-Oncology Program 
    1/12/2015
  • Issues in Breast Cancer Therapy 
    University of South Florida, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL - 1/1/2015
  • Triple Negative breast cancer 
    1/1/2015
  • Join now to see all

Other

  • Cardio-Oncology: An Important New Specialty to Improve Patient Outcomes 
    Ismail-Khan R and Fradley M
    University of South Florida and Moffitt Cancer Center - 1/1/2015
  • Triple Negative Breast Cancer 
    Ismail-Khan R, International Hospital and Equipment (IHE), PanGlobal Media
    1/1/2010
  • Why Focus on Triple Negative Breast Cancer? 
    Ismail-Khan R, Factors Publications

Press Mentions

  • BRCA Carriers Can Benefit From Mutations
    BRCA Carriers Can Benefit From MutationsSeptember 28, 2020 06:34
  • Moffitt Cancer Center Takes Whole-Patient Treatment to Heart
    Moffitt Cancer Center Takes Whole-Patient Treatment to HeartSeptember 28, 2020 06:32
  • Perspectives: The Benefit of Cardio- Oncology Programs for Cancer Patients
    Perspectives: The Benefit of Cardio- Oncology Programs for Cancer PatientsSeptember 28, 2020 06:30
  • Join now to see all

Professional Memberships

Other Languages

  • Urdu, Hindi, Spanish

Hospital Affiliations